伴有CBFB-MYH11重排的急性髓系白血病在所有病例中有92%表现出RAS通路改变，包括高频率的NF1缺失。 - Suppr

Suppr

超能文献

AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions.

作者信息

Haferlach C, Dicker F, Kohlmann A, Schindela S, Weiss T, Kern W, Schnittger S, Haferlach T

出版信息

Leukemia. 2010 May;24(5):1065-9. doi: 10.1038/leu.2010.22. Epub 2010 Feb 18.

DOI:10.1038/leu.2010.22

PMID:20164853

Abstract

摘要

相似文献

AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions.伴有CBFB-MYH11重排的急性髓系白血病在所有病例中有92%表现出RAS通路改变，包括高频率的NF1缺失。

Leukemia. 2010 May;24(5):1065-9. doi: 10.1038/leu.2010.22. Epub 2010 Feb 18.

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.多梳蛋白相关基因ASXL1在骨髓增生异常综合征和急性髓系白血病中频繁发生突变。

Leukemia. 2010 May;24(5):1062-5. doi: 10.1038/leu.2010.20. Epub 2010 Feb 25.

Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.神经纤维瘤病-1 基因缺失和突变在新诊断的成人急性髓系白血病中。

Am J Hematol. 2013 Apr;88(4):306-11. doi: 10.1002/ajh.23403. Epub 2013 Mar 5.

Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.青少年粒单核细胞白血病的全基因组单核苷酸多态性分析表明，在与神经纤维瘤病相关的病例中，NF1基因座周围存在单亲二体性，而在具有RAS或PTPN11突变的病例中则不存在。

Oncogene. 2007 Aug 23;26(39):5816-21. doi: 10.1038/sj.onc.1210361. Epub 2007 Mar 12.

The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemia.在90%的CBFB-MYH11阳性急性髓系白血病病例中，NDE1基因被inv(16)破坏。

Leukemia. 2010 Apr;24(4):857-9. doi: 10.1038/leu.2009.290. Epub 2010 Jan 14.

Gene expression analysis reveals HOX gene upregulation in trisomy 8 AML.基因表达分析显示8号染色体三体急性髓系白血病中HOX基因上调。

Leukemia. 2010 Jun;24(6):1239-43. doi: 10.1038/leu.2010.85. Epub 2010 Apr 29.

Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.伴有inv(16)/t(16;16)的急性髓系白血病中罕见的CBFB-MYH11融合转录本与治疗相关的急性髓系白血病M4eo、非典型细胞形态学、非典型免疫表型、非典型额外染色体重排及低白细胞计数相关：一项对162例患者的研究

Leukemia. 2007 Apr;21(4):725-31. doi: 10.1038/sj.leu.2404531. Epub 2007 Feb 8.

Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.通过实时逆转录聚合酶链反应检测和定量inv(16)阳性急性髓性白血病患者中的CBFB/MYH11融合转录本

Genes Chromosomes Cancer. 2001 Apr;30(4):342-8. doi: 10.1002/gcc.1100.

[Fluorescence in situ hybridization study of acute myeloid leukemia with cryptic chromosome rearrangements].[隐匿性染色体重排急性髓系白血病的荧光原位杂交研究]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Dec;28(6):690-3. doi: 10.3760/cma.j.issn.1003-9406.2011.06.021.

Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.一名儿科患者出现伴有CBFB-MYH11的inv(16)、3'CBFB缺失、伴有BCR-ABL1的变异t(9;22)以及del(7)(q22q32)的急性髓系白血病：病例报告及文献综述

Cancer Genet Cytogenet. 2010 Jul 1;200(1):54-9. doi: 10.1016/j.cancergencyto.2010.03.001.

引用本文的文献

The Fusion Genes and Their Relation with Genetic Variants in Egyptian AML Patients.埃及急性髓系白血病患者中的融合基因及其与基因变异的关系。

Asian Pac J Cancer Prev. 2025 Mar 1;26(3):1069-1078. doi: 10.31557/APJCP.2025.26.3.1069.

Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia.基因异常可预测核心结合因子急性髓系白血病患者的预后。

Ann Hematol. 2025 Feb;104(2):997-1006. doi: 10.1007/s00277-024-06182-0. Epub 2025 Jan 10.

Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients.比较维奈克拉联合低甲基化药物与强化化疗作为初诊核心结合因子急性髓系白血病患者诱导治疗的疗效和安全性。

Blood Cancer J. 2025 Feb 11;15(1):17. doi: 10.1038/s41408-025-01227-7.

CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer.CBF-β 通过 PIM1 减轻 PI3K-α 特异性抑制剂在 PIK3CA 突变型胃癌中的杀伤作用。

Mol Cancer Res. 2023 Nov 1;21(11):1148-1162. doi: 10.1158/1541-7786.MCR-23-0034.

ASXL1/2 mutations and myeloid malignancies.ASXL1/2 突变与髓系恶性肿瘤。

J Hematol Oncol. 2022 Sep 6;15(1):127. doi: 10.1186/s13045-022-01336-x.

Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia.在成人急性髓系白血病中表达下调且是一种预后生物标志物。

Front Oncol. 2020 Feb 27;10:204. doi: 10.3389/fonc.2020.00204. eCollection 2020.

Acute myeloid leukemia with inv(16)(p13.1q22) and deletion of the 5'MYH11/3'CBFB gene fusion: a report of two cases and literature review.伴有inv(16)(p13.1q22)及5'MYH11/3'CBFB基因融合缺失的急性髓系白血病：两例报告及文献复习

Mol Cytogenet. 2020 Jan 30;13:4. doi: 10.1186/s13039-020-0474-9. eCollection 2020.

The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations.FLT3 和 SYK 激酶抑制剂的联合使用对带有 CBL 突变的白血病细胞有毒性。

J Cell Mol Med. 2020 Feb;24(3):2145-2156. doi: 10.1111/jcmm.14820. Epub 2020 Jan 14.

Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.比较米哚妥林、克立替尼、quizartinib、吉特替尼、索拉非尼和 BLU-285 对血液系统恶性肿瘤中 KIT、CBL 和 FLT3 致癌突变体的影响。

Br J Haematol. 2019 Nov;187(4):488-501. doi: 10.1111/bjh.16092. Epub 2019 Jul 15.

IL1RL1 is dynamically expressed on Cbfb-MYH11 leukemia stem cells and promotes cell survival.IL1RL1 在 Cbfb-MYH11 白血病干细胞上动态表达，并促进细胞存活。

Sci Rep. 2019 Feb 11;9(1):1729. doi: 10.1038/s41598-018-38408-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验